SIREN : 909382442
BR LR is a French company founded 4 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in CAISSARGUES (30132), this company of category ETI shows in 2025 a revenue of 5.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 5 226 977 € | 5 328 926 € | 5 174 962 € | N/C |
| Net income | 367 583 € | 1 019 366 € | 930 352 € | -422 € |
| EBITDA | 732 856 € | 1 267 737 € | 1 226 210 € | -199 € |
| Net margin | 7.0% | 19.1% | 18.0% | N/C |
In 2025, BR LR achieves revenue of 5.2 M€. Revenue is growing positively over 4 years (CAGR: +0.5%). Slight decline of -2% vs 2024. After deducting consumption (489 k€), gross margin stands at 4.7 M€, i.e. a rate of 91%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 733 k€, representing 14.0% of revenue. Warning negative scissor effect: despite revenue change (-2%), EBITDA varies by -42%, reducing margin by 9.8 pts. This reflects costs rising faster than revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 368 k€, i.e. 7.0% of revenue. This profit can be retained or distributed to shareholders.
5 226 977 €
4 738 282 €
732 856 €
713 762 €
367 583 €
14.0%
The debt ratio (= Financial debt / Equity x 100) stands at 47%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 26%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.4 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 7.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
47.49%
26.285%
7.266%
1.393
57.3%
In 2025, the debt ratio of BR LR (47.49) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2025, the financial autonomy of BR LR (26.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2025, the repayment capacity of BR LR (1.39) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 163.01. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 40.7x. Operating income very largely covers interest expenses: high safety margin.
163.014
40.722
In 2025, the liquidity ratio of BR LR (163.01) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2025, the interest coverage of BR LR (40.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 20 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 227 days. Excellent situation: suppliers finance 207 days of the operating cycle (retail model). Inventory turnover is 8 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 270 days of revenue, i.e. 3.9 M€ to permanently finance.
3 925 407 €
20 j
227 j
8 j
270 j
Based on 124 transactions of similar company sales (all years), the value of BR LR is estimated at 652 281 € (range 326 016€ - 2 170 882€). With an EBITDA of 732 856€, the sector multiple of 0.7x is applied. The price/revenue ratio is 0.21x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BR LR with other companies in the same sector:
The revenue of BR LR in 2025 is 5.2 M€.
Yes, BR LR generated a net profit of 368 k€ in 2025.
The headquarters of BR LR is located in CAISSARGUES (30132), in the department Gard.
The tax return of BR LR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BR LR operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.